Concept Life Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
37
About the Report
About the Report
Summary
Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytical services. its analytical services include life sciences, food and consumer services, industrial and environmental services, chemicals and online reporting. The company caters its services to pharmaceutical, biotechnology, petrochemical, agrochemical, chemical and consumer products industries. It has operations across the UK. Concept Life Sciences is headquartered in Manchester, the UK.
Concept Life Sciences Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Concept Life Sciences Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12
Partnerships 13
Concept Life Sciences and Alderley Analytical Enter into Partnership 13
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14
Metrion Biosciences Enters into Agreement with Concept Life Sciences 15
Acquisition 16
Spectris Acquires Concept Life Sciences for USD232 Million 16
Concept Life Sciences Acquires Aquila BioMedical 17
Concept Life Sciences Acquires CXR Biosciences 18
Concept Life Sciences Acquires Peakdale Molecular 19
Concept Life Sciences Acquires Scientific Analysis Laboratories 20
Concept Life Sciences Acquires Resource and Environmental Consultants 21
Concept Life Sciences Ltd-Key Competitors 22
Concept Life Sciences Ltd-Key Employees 23
Concept Life Sciences Ltd-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Sep 12, 2017: Concept Life Sciences expands into Alderley Park to support discovery services growth 25
Financial Announcements 26
Dec 18, 2017: Concept Life Sciences Achieves Record Profits and Strengthens Senior Team 26
Corporate Communications 27
Aug 13, 2018: Concept Life Sciences appoints Sarah Harris as East Coast business development director 27
Jun 26, 2018: Concept Life Sciences Names John Vu as West Coast Business Development Director 28
Oct 24, 2017: Concept Life Sciences appoints Philip Payne as Chief Commercial Officer 29
Aug 17, 2017: Concept Life Sciences Announces the Appointment of John Handley as Chief Operating Officer as the Company Prepares for the Next Stage of Growth and Development 30
Aug 03, 2017: Concept Life Sciences Strengthens Senior Management Team 31
Apr 03, 2017: Concept Life Sciences Further Strengthens Its Senior Team 32
Legal and Regulatory 33
Feb 08, 2018: Concept Life Sciences Expands GXP Compliance 33
Other Significant Developments 34
Jul 11, 2018: Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity 34
Nov 29, 2017: Concept Life Sciences Invests in East Kilbride Analytical Services Facility 35
Mar 01, 2017: Concept Life Sciences Group Announces Multi-Million Pound Expansion Programme And Rebranding 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Concept Life Sciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12
Concept Life Sciences and Alderley Analytical Enter into Partnership 13
Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14
Metrion Biosciences Enters into Agreement with Concept Life Sciences 15
Spectris Acquires Concept Life Sciences for USD232 Million 16
Concept Life Sciences Acquires Aquila BioMedical 17
Concept Life Sciences Acquires CXR Biosciences 18
Concept Life Sciences Acquires Peakdale Molecular 19
Concept Life Sciences Acquires Scientific Analysis Laboratories 20
Concept Life Sciences Acquires Resource and Environmental Consultants 21
Concept Life Sciences Ltd, Key Competitors 22
Concept Life Sciences Ltd, Key Employees 23
Concept Life Sciences Ltd, Other Locations 24
Concept Life Sciences Ltd, Subsidiaries 24
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.